drug · Product Intelligence

BIA 2-093
Pipeline Intelligence

BIA 2-093: 6 indexed trials, 1 sponsors; 0 linked Orange Book patents and 0 FDA-linked events where matched.

⚗
6Indexed trials
▦
1Sponsors
⌁
0Orange Book patent links
◎
0FDA-linked events

Development evidence

NCT02170077Bial - Portela C S.A. · epilepsyPHASE2
NCT02172742Bial - Portela C S.A. · epilepsyPHASE1
NCT02281526Bial - Portela C S.A. · epilepsyPHASE1
NCT02283814Bial - Portela C S.A. · epilepsyPHASE1
NCT02283827Bial - Portela C S.A. · epilepsyPHASE1
NCT02777671Bial - Portela C S.A. · epilepsyPHASE1

FDA / patent evidence

No FDA Orange Book product match is asserted for this intervention.

Regulatory context

FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.